{"id":74446,"date":"2021-07-13T17:16:00","date_gmt":"2021-07-13T15:16:00","guid":{"rendered":"https:\/\/cms.munich-startup.net\/?p=74446"},"modified":"2021-07-13T15:57:43","modified_gmt":"2021-07-13T13:57:43","slug":"eisbach-bio-receives-8-million-euros-in-state-funding","status":"publish","type":"post","link":"https:\/\/cms.munich-startup.net\/en\/74446\/eisbach-bio-receives-8-million-euros-in-state-funding\/","title":{"rendered":"Eisbach Bio receives 8 million euros in state funding"},"content":{"rendered":"<div class=\"entry-content\">\n<p>Eisbach Bio develops drugs for serious diseases such as cancer. The Munich-based biotech company, based in <a href=\"\/en\/19098\/asked-at-the-izb\/\">Biotechnology Innovation and Start-up Center (IZB)<\/a> in Martinsried is also working on a targeted drug for the SARS-CoV-2 enzyme Nsp13. The Federal Ministry is now supporting the clinical validation of the drug. Eisbach&#039;s CEO, <strong>Adrian Schomburg<\/strong>, says:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>&quot;We are very grateful for the BMBF&#039;s support in the clinical validation of our drug candidate, which would enable convenient oral administration. Because the tablets can be easily manufactured and shipped, our drug candidate offers broad potential not only to alleviate disease symptoms but also to reduce the number of COVID-19 hospitalizations and deaths worldwide.&quot;<\/p><\/blockquote>\n\n\n\n<h2 class=\"wp-block-heading\">Clinical trials for Eisbach Bio&#039;s COVID drug to start in the first quarter of 2022<\/h2>\n\n\n\n<p>The Eisbach CSO <strong>Andreas Ladurner <\/strong>says:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>&quot;Our drug blocks viral replication through a novel mechanism that is fully conserved across all known virus variants. We are committed to developing a sustainable drug with a good safety profile that should enable the treatment of all individuals who test positive for SARS-CoV-2, especially high-risk patients.&quot;<\/p><\/blockquote>\n\n\n\n<p>The company expects to begin Phase I clinical trials for its COVID-19 drug in the first quarter of 2022.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>&quot;We are very proud that top researchers from the Bavarian Silicon Valley will also be contributing to meeting the high medical need for effective COVID-19 drugs. Congratulations to the team led by Dr. Adrian Schomburg and Prof. Andreas Ladurner from Eisbach Bio on receiving funding from the Federal Ministry of Education and Research (BMBF).&quot;<\/p><\/blockquote>\n\n\n\n<p>says <strong>Peter Hanns Zobel<\/strong>, Managing Director of the IZB.<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Eisbach Bio has received \u20ac8 million in funding from the German Federal Ministry of Education and Research (BMBF) for the clinical development of a COVID-19 drug. Preclinical development was recently completed.<\/p>","protected":false},"author":26,"featured_media":13666,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5633,1,5635],"tags":[371,3882,4344,52,1499],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Eisbach Bio erh\u00e4lt 8 Millionen Euro staatliche F\u00f6rderung - Munich Startup<\/title>\n<meta name=\"description\" content=\"Eisbach Bio erh\u00e4lt vom BMBF f\u00fcr die klinische Entwicklung eines COVID-19-Medikaments eine F\u00f6rderung in H\u00f6he von 8 Millionen Euro.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/74446\/eisbach-bio-receives-8-million-euros-in-state-funding\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eisbach Bio erh\u00e4lt 8 Millionen Euro staatliche F\u00f6rderung - Munich Startup\" \/>\n<meta property=\"og:description\" content=\"Eisbach Bio erh\u00e4lt vom BMBF f\u00fcr die klinische Entwicklung eines COVID-19-Medikaments eine F\u00f6rderung in H\u00f6he von 8 Millionen Euro.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/74446\/eisbach-bio-receives-8-million-euros-in-state-funding\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-13T15:16:00+00:00\" \/>\n<meta name=\"author\" content=\"Simon Tischer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Simon Tischer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/en\/74446\/eisbach-bio-receives-8-million-euros-in-state-funding\/\",\"url\":\"https:\/\/cms.munich-startup.net\/en\/74446\/eisbach-bio-receives-8-million-euros-in-state-funding\/\",\"name\":\"Eisbach Bio erh\u00e4lt 8 Millionen Euro staatliche F\u00f6rderung - Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/en\/74446\/eisbach-bio-receives-8-million-euros-in-state-funding\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/en\/74446\/eisbach-bio-receives-8-million-euros-in-state-funding\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/08\/izb-eingang.jpg\",\"datePublished\":\"2021-07-13T15:16:00+00:00\",\"author\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/cab6cd082a88a9e4b2d6ca61a9031a4d\"},\"description\":\"Eisbach Bio erh\u00e4lt vom BMBF f\u00fcr die klinische Entwicklung eines COVID-19-Medikaments eine F\u00f6rderung in H\u00f6he von 8 Millionen Euro.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/en\/74446\/eisbach-bio-receives-8-million-euros-in-state-funding\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/en\/74446\/eisbach-bio-receives-8-million-euros-in-state-funding\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/en\/74446\/eisbach-bio-receives-8-million-euros-in-state-funding\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/08\/izb-eingang.jpg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/08\/izb-eingang.jpg\",\"width\":850,\"height\":566,\"caption\":\"Eisbach Bio Pieris Pharmaceuticals Finanzierung\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/en\/74446\/eisbach-bio-receives-8-million-euros-in-state-funding\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eisbach Bio erh\u00e4lt 8 Millionen Euro staatliche F\u00f6rderung\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/cab6cd082a88a9e4b2d6ca61a9031a4d\",\"name\":\"Simon Tischer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/0768e5403c34aa0074a7e723cd3a2795?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/0768e5403c34aa0074a7e723cd3a2795?s=96&d=blank&r=g\",\"caption\":\"Simon Tischer\"},\"description\":\"Von Dezember 2015 bis Juni 2023 war Simon Tischer als Redakteur f\u00fcr Munich Startup t\u00e4tig.\",\"url\":\"https:\/\/cms.munich-startup.net\/en\/author\/tischer\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2016\/08\/izb-eingang.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"850\" \/>\n\t<meta property=\"og:image:height\" content=\"566\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Eisbach Bio receives 8 million euros in state funding - Munich Startup","description":"Eisbach Bio receives funding of 8 million euros from the BMBF for the clinical development of a COVID-19 drug.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/74446\/eisbach-bio-receives-8-million-euros-in-state-funding\/","og_locale":"en_US","og_type":"article","og_title":"Eisbach Bio erh\u00e4lt 8 Millionen Euro staatliche F\u00f6rderung - Munich Startup","og_description":"Eisbach Bio erh\u00e4lt vom BMBF f\u00fcr die klinische Entwicklung eines COVID-19-Medikaments eine F\u00f6rderung in H\u00f6he von 8 Millionen Euro.","og_url":"https:\/\/cms.munich-startup.net\/en\/74446\/eisbach-bio-receives-8-million-euros-in-state-funding\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_published_time":"2021-07-13T15:16:00+00:00","author":"Simon Tischer","twitter_card":"summary_large_image","twitter_creator":"@munich_startup","twitter_site":"@munich_startup","twitter_misc":{"Written by":"Simon Tischer","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/en\/74446\/eisbach-bio-receives-8-million-euros-in-state-funding\/","url":"https:\/\/cms.munich-startup.net\/en\/74446\/eisbach-bio-receives-8-million-euros-in-state-funding\/","name":"Eisbach Bio receives 8 million euros in state funding - Munich Startup","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/en\/74446\/eisbach-bio-receives-8-million-euros-in-state-funding\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/en\/74446\/eisbach-bio-receives-8-million-euros-in-state-funding\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/08\/izb-eingang.jpg","datePublished":"2021-07-13T15:16:00+00:00","author":{"@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/cab6cd082a88a9e4b2d6ca61a9031a4d"},"description":"Eisbach Bio receives funding of 8 million euros from the BMBF for the clinical development of a COVID-19 drug.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/en\/74446\/eisbach-bio-receives-8-million-euros-in-state-funding\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/en\/74446\/eisbach-bio-receives-8-million-euros-in-state-funding\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/en\/74446\/eisbach-bio-receives-8-million-euros-in-state-funding\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/08\/izb-eingang.jpg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/08\/izb-eingang.jpg","width":850,"height":566,"caption":"Eisbach Bio Pieris Pharmaceuticals Finanzierung"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/en\/74446\/eisbach-bio-receives-8-million-euros-in-state-funding\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"Eisbach Bio erh\u00e4lt 8 Millionen Euro staatliche F\u00f6rderung"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/cab6cd082a88a9e4b2d6ca61a9031a4d","name":"Simon Tischer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/0768e5403c34aa0074a7e723cd3a2795?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0768e5403c34aa0074a7e723cd3a2795?s=96&d=blank&r=g","caption":"Simon Tischer"},"description":"From December 2015 to June 2023, Simon Tischer worked as an editor for Munich Startup.","url":"https:\/\/cms.munich-startup.net\/en\/author\/tischer\/"}]},"og_image":[{"width":850,"height":566,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/08\/izb-eingang.jpg","type":"image\/jpeg"}]},"_showyear":"","_inactive":"","_show_financing":"","_hide_on_map":"","_edit_lock":"1638443725:38","_edit_last":"33","_yoast_wpseo_focuskw":"Eisbach","_yoast_wpseo_metadesc":"Eisbach Bio erh\u00e4lt vom BMBF f\u00fcr die klinische Entwicklung eines COVID-19-Medikaments eine F\u00f6rderung in H\u00f6he von 8 Millionen Euro.","_yoast_wpseo_linkdex":"75","_thumbnail_id":"13666","wbounce_status":"default","_yoast_wpseo_primary_category":"5633","_yoast_wpseo_focuskw_text_input":"","_yoast_wpseo_content_score":"30","ms_image_format":"contentwidth","_ms_image_format":"field_5cb8587572c8b","ms_dachzeile":"","_ms_dachzeile":"field_5cd9b7f365df5","ms_bump_post_date":"","_ms_bump_post_date":"field_5d1341edcf42a","guest_author_name":"","_guest_author_name":"field_5cee78a6016f9","guest_author_image":"","_guest_author_image":"field_5cee7914016fb","guest_author_description":"","_guest_author_description":"field_5cee78dd016fa","ms_post_image_caption":"","_ms_post_image_caption":"field_5f735b0735284","ms_post_image_credit":"","_ms_post_image_credit":"field_5f735b1435285","suppress_startupbox":"0","_suppress_startupbox":"field_60a64b0b6efc6","_yoast_wpseo_estimated-reading-time-minutes":"2","_wp_old_date":"","_yoast_wpseo_title":"","_yoast_wpseo_wordproof_timestamp":"","footnotes":"","easy_language_simplification_original_id":"","easy_language_source_language":"","easy_language_simplification_language":"","easy_language_api":"","easy_language_prevent_automatic_mode":"","_wp_old_slug":"","_wp_trash_meta_status":"","_wp_trash_meta_time":"","easy_language_simplification_state_changed_from":"","easy_language_de_EL_changed":"","ms_competition_deadline":"","_ms_competition_deadline":"","_wpbitly":"","enclosure":"","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","wbounce_template":"","wbounce_title":"","wbounce_text":"","wbounce_cta":"","wbounce_url":"","wbounce_override":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_oembed_7131efca3705e16bd9da2c41df237660":"","_oembed_time_7131efca3705e16bd9da2c41df237660":"","_pprredirect_type":"","_pprredirect_url":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":"","_newsletterglue":"","easy_language_text_language":"","_wp_desired_post_slug":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/74446"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=74446"}],"version-history":[{"count":2,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/74446\/revisions"}],"predecessor-version":[{"id":74450,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/74446\/revisions\/74450"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/13666"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=74446"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/categories?post=74446"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=74446"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}